Drug intelligence / Profile preview

Brodclav

Development stage
Phase 4
Lead developer
Man Serve Pharma
Modality
Small Molecules
Administration
Intramuscular, Intravenous, Oral
01

Overview

Brodclav is a combination antibiotic containing amoxicillin, a semisynthetic penicillin-class beta-lactam antibiotic, and clavulanic acid (as potassium clavulanate), a beta-lactamase inhibitor. Amoxicillin works by binding to and inactivating penicillin-binding proteins (PBPs) involved in bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic acid acts as a suicide inhibitor of bacterial beta-lactamases, preventing the enzymatic degradation of amoxicillin and restoring its activity against beta-lactamase-producing resistant strains. Brodclav is used to treat a wide range of bacterial infections, including respiratory tract, urinary tract, skin, and soft tissue infections.

Brand names
Brodclav
Other names
amoxicillin + clavulanic acidamoxicillin + potassium clavulanateco-amoxiclav
02

Targets

β-lactamasePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Brodclav.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brodclav.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call